Jennifer Doan

Array ( [id] => 972329 [patent_doc_number] => 06936714 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-30 [patent_title] => 'Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof' [patent_app_type] => utility [patent_app_number] => 10/728580 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 10133 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/936/06936714.pdf [firstpage_image] =>[orig_patent_app_number] => 10728580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474252 [patent_doc_number] => 20040122023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine' [patent_app_type] => new [patent_app_number] => 10/724611 [patent_app_country] => US [patent_app_date] => 2003-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10990 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20040122023.pdf [firstpage_image] =>[orig_patent_app_number] => 10724611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474243 [patent_doc_number] => 20040122021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Enantiomers of 1-[(4-chlorophenyl)phenylmethyl)-4-[(4-methylphenyl)sulfonyl) piperazine' [patent_app_type] => new [patent_app_number] => 10/724640 [patent_app_country] => US [patent_app_date] => 2003-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10884 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20040122021.pdf [firstpage_image] =>[orig_patent_app_number] => 10724640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5801470 [patent_doc_number] => 20060035906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Process for production of 1-[2-(benzimidazol-2-yl- thio)ethy]piperazine or salts thereof' [patent_app_type] => utility [patent_app_number] => 10/535705 [patent_app_country] => US [patent_app_date] => 2003-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3166 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035906.pdf [firstpage_image] =>[orig_patent_app_number] => 10535705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474724 [patent_doc_number] => 20040097518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Quinoline derivatives as nk-3 antagonists' [patent_app_type] => new [patent_app_number] => 10/432925 [patent_app_country] => US [patent_app_date] => 2003-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24527 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097518.pdf [firstpage_image] =>[orig_patent_app_number] => 10432925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7291170 [patent_doc_number] => 20040110765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => '3-(Pyridinyl-piperazin-1-yl)-phenylethyl amides as potassium channel openers' [patent_app_type] => new [patent_app_number] => 10/719188 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5944 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110765.pdf [firstpage_image] =>[orig_patent_app_number] => 10719188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325432 [patent_doc_number] => 20040138228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Novel compounds with analgesic effect' [patent_app_type] => new [patent_app_number] => 10/714447 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21456 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138228.pdf [firstpage_image] =>[orig_patent_app_number] => 10714447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7432874 [patent_doc_number] => 20040162295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Pharmaceutical compound' [patent_app_type] => new [patent_app_number] => 10/477192 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4068 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162295.pdf [firstpage_image] =>[orig_patent_app_number] => 10477192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325418 [patent_doc_number] => 20040138225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Novel compounds' [patent_app_type] => new [patent_app_number] => 10/714448 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4872 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138225.pdf [firstpage_image] =>[orig_patent_app_number] => 10714448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674615 [patent_doc_number] => 20040127503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => '17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases' [patent_app_type] => new [patent_app_number] => 10/713828 [patent_app_country] => US [patent_app_date] => 2003-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9296 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127503.pdf [firstpage_image] =>[orig_patent_app_number] => 10713828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7169503 [patent_doc_number] => 20040077655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Piperazine derivatives for treatment of bacterial infections' [patent_app_type] => new [patent_app_number] => 10/450884 [patent_app_country] => US [patent_app_date] => 2003-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19099 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077655.pdf [firstpage_image] =>[orig_patent_app_number] => 10450884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7169512 [patent_doc_number] => 20040077656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents' [patent_app_type] => new [patent_app_number] => 10/450892 [patent_app_country] => US [patent_app_date] => 2003-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16069 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077656.pdf [firstpage_image] =>[orig_patent_app_number] => 10450892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7447673 [patent_doc_number] => 20040186108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Phenylalkyl and pyridylalkyl piperazine derivatives' [patent_app_type] => new [patent_app_number] => 10/703333 [patent_app_country] => US [patent_app_date] => 2003-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45857 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20040186108.pdf [firstpage_image] =>[orig_patent_app_number] => 10703333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5875322 [patent_doc_number] => 20060167004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => '4(Phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders' [patent_app_type] => utility [patent_app_number] => 10/533744 [patent_app_country] => US [patent_app_date] => 2003-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9632 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20060167004.pdf [firstpage_image] =>[orig_patent_app_number] => 10533744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111822 [patent_doc_number] => 20050209278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors' [patent_app_type] => utility [patent_app_number] => 10/700202 [patent_app_country] => US [patent_app_date] => 2003-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 142862 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209278.pdf [firstpage_image] =>[orig_patent_app_number] => 10700202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 885056 [patent_doc_number] => 07351828 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-01 [patent_title] => 'Benzimidazoles that are useful in treating sexual dysfunction' [patent_app_type] => utility [patent_app_number] => 10/699465 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26181 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/351/07351828.pdf [firstpage_image] =>[orig_patent_app_number] => 10699465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7225279 [patent_doc_number] => 20040072838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors' [patent_app_type] => new [patent_app_number] => 10/451295 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74414 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072838.pdf [firstpage_image] =>[orig_patent_app_number] => 10451295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5591500 [patent_doc_number] => 20060040952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Il-8 receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/532956 [patent_app_country] => US [patent_app_date] => 2003-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10346 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040952.pdf [firstpage_image] =>[orig_patent_app_number] => 10532956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7310559 [patent_doc_number] => 20040142933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Oxindole substituted piperazine derivatives' [patent_app_type] => new [patent_app_number] => 10/695594 [patent_app_country] => US [patent_app_date] => 2003-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13408 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142933.pdf [firstpage_image] =>[orig_patent_app_number] => 10695594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7386588 [patent_doc_number] => 20040082589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Quinoline derivatives as nk-3 and nk-2 antagonists' [patent_app_type] => new [patent_app_number] => 10/416596 [patent_app_country] => US [patent_app_date] => 2003-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17017 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082589.pdf [firstpage_image] =>[orig_patent_app_number] => 10416596 [rel_patent_id] =>[rel_patent_doc_number] =>)